Clinical and Genetic Risk Factors for the Prediction Of Hepatotoxicity Induced by a Docetaxel, Epirubicin and Cyclophosphamide⟒egimen in Breast Cancer Patients

References

• Gradishar WJ , AndersonBO , AbrahamJet al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J. Natl Compr. Canc. Netw.18(4), 452–478 (2020).
   PubMedGoogle Scholar
• Vriens BEPJ , VriensIJH , AartsMJBet al. Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer. Breast Cancer Res. Treat.165(3), 593–600 (2017).
   PubMed Web of Science ®Google Scholar
• Wills SM , ReidR , JaiyesimiI , MargolisJ. Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide. J. Clin. Oncol.28(15), (2010).
   Web of Science ®Google Scholar
• Andrade RJ , AithalGP , BjörnssonESet al. EASL clinical practice guidelines: drug-induced liver injury. J. Hepatol.70, 1222–1261 (2019).
   PubMed Web of Science ®Google Scholar
• Li B , LiW , TianYet al. Selenium-alleviated hepatocyte necrosis and DNA damage in cyclophosphamide-treated geese by mitigating oxidative stress. Biol. Trace Elem. Res.193, 508–516 (2020).
   PubMed Web of Science ®Google Scholar
• Henninger C , HuelsenbeckJ , HuelsenbeckSet al. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity. Toxicol. Appl. Pharmacol.261, 66–73 (2012).
   PubMed Web of Science ®Google Scholar
• Li AN , LiS , ZhangYJ , XuXR , ChenYM , LiHB. Resources and biological activities of natural polyphenols. Nutrients6, 6020–6047 (2014).
   PubMed Web of Science ®Google Scholar
• Saithanyamurthi H , FaustAJ. Drug-induced liver disease: clinical course. Clin. Liver Dis.21, 21–34 (2017).
   PubMed Web of Science ®Google Scholar
• Chalasani NP , HayashiPH , BonkovskyHL , NavarroVJ , LeeWM , FontanaRJ. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am. J. Gastroenterol.109, 950 (2014).
   PubMed Web of Science ®Google Scholar
• Stine JG , LewisJH. Drug-induced liver injury: a summary of recent advances. Expert Opin. Drug Metab. Toxicol.7, 875–890 (2011).
   PubMed Web of Science ®Google Scholar
• Martinez MA , VuppalanchiR , FontanaRJet al. Clinical and histologic features of azithromycin-induced liver injury. Clin. Gastroenterol. Hepatol.13, 369–376 (2015).
   PubMed Web of Science ®Google Scholar
• Sharma SK , BalamuruganA , SahaPK , PandeyRM , MehraNK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am. J. Respir. Crit. Care Med.166, 916–919 (2002).
   PubMed Web of Science ®Google Scholar
• Pukenyte E , LescureF , ReyDet al. Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment. Int. J. Tuberc. Lung Dis.11, 78–84 (2007).
   PubMed Web of Science ®Google Scholar
• Wang Z , LiangX , YuJet al. Non-genetic risk factors and predicting efficacy for docetaxel–drug-induced liver injury among metastatic breast cancer patients. J. Gastroenterol. Hepatol.27, 1348–1352 (2012).
   PubMed Web of Science ®Google Scholar
• Petros Z , LeeMTM , TakahashiAet al. Genome-wide association and replication study of hepatotoxicity induced by antiretrovirals alone or with concomitant anti-tuberculosis drugs. OMICS21, 207–216 (2017).
   PubMed Web of Science ®Google Scholar
• Megías-Vericat JE , MontesinosP , HerreroMJet al. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leuk. Lymphoma58, 1197–1206 (2017).
   PubMed Web of Science ®Google Scholar
• Thorn CF , OshiroC , MarshSet al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet. Genomics21, 440–446 (2011).
   PubMed Web of Science ®Google Scholar
• Van-Waterschoot RA , LagasJS , WagenaarE , RosingH , BeijinenJH , SchinkelAH. Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel. Int. J. Cancer127, 2959–2964 (2010).
   PubMed Web of Science ®Google Scholar
• Qiu R , KalhornTF , SlatteryJT. ABCC2-mediated biliary transport of 4-glutathionylcyclophosphamide and its contribution to elimination of 4-hydroxycyclophosphamide in rat. J. Pharmacol. Exp. Ther.308, 1204–1214 (2004).
   PubMed Web of Science ®Google Scholar
• Dimeloe S , FrickC , FischerMet al. Human regulatory T cells lack the cyclophosphamide-extruding transporter ABCB1 and are more susceptible to cyclophosphamide-induced apoptosis. Eur. J. Immunol.44, 3614–3620 (2014).
   PubMed Web of Science ®Google Scholar
• Dai C , MaS , WangFet al. Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes. Oncotarget6, 17738 (2015).
   PubMed Web of Science ®Google Scholar
• Pilcoferreto N , CalafGM. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. Int. J. Oncol.49, 753–762 (2016).
   PubMed Web of Science ®Google Scholar
• Cheung KG , ColeLK , XiangBet al. Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes. J. Biol. Chem.290, 10981–10993 (2015).
   PubMed Web of Science ®Google Scholar
• Yao S , BarlowWE , AlbainKSet al. Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer. Breast Cancer Res. Treat.124, 433–439 (2010).
   PubMed Web of Science ®Google Scholar
• Fukunaga K , NakagawaH , IshikawaT , KuboM , MushirodaT. ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population. BMC Genet.17, 79 (2016).
   PubMed Web of Science ®Google Scholar
• Alachkar H , FultonN , SanfordBet al. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. Pharmacogenomics J.17, 274–279 (2017).
   PubMed Web of Science ®Google Scholar
• Fontana RJ , WatkinsPB , BonkovskyHLet al. Drug-induced liver injury network (DILIN) prospective study. Drug Saf.32, 55–68 (2009).
   PubMed Web of Science ®Google Scholar
• Tecza K , Pamula-PilatJ , LanuszewskaJ , ButkiewiczD , GrzybowskaE. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget9, 9114 (2018).
   PubMedGoogle Scholar
• Lavanderos MA , CayunJP , RocoAMet al. Association study among candidate genetic polymorphisms and chemotherapy-related severe toxicity in testicular cancer patients. Front. Pharmacol.10, 206 (2019).
   PubMed Web of Science ®Google Scholar
• Coelho AV , SilvaSP , DeAlencar LCet al. ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. J. Clin. Pharmacol.53, 1286–1293 (2013).
   PubMed Web of Science ®Google Scholar
• Vulsteke C , PfeilAM , MaggenCet al. Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Res. Treat.152, 67–76 (2015).
   PubMed Web of Science ®Google Scholar
• Pfeil AM , VulstekeC , ParidaensRet al. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer14, 201 (2014).
   PubMed Web of Science ®Google Scholar
• Warren RB , SmithRL , CampalaniEet al. Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J. Invest. Dermatol.128, 1925–1929 (2008).
   PubMed Web of Science ®Google Scholar
• Franca R , ReboraP , BertorelloNet al. Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol. Pharmacogenomics J.17, 4–10 (2017).
   PubMed Web of Science ®Google Scholar
• Cao HX , MiaoCF , YanL , TangP , ZhangLR , SunL. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients. J. Transl. Med.15, 235 (2017).
   PubMed Web of Science ®Google Scholar
• Vulsteke C , LambrechtsD , DieudonnéAet al. Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). Ann. Oncol.24, 1513–1525 (2013).
   PubMed Web of Science ®Google Scholar
• Ranganathan P , CulverhouseR , MarshSet al. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J. Rheumatol.35, 572–579 (2008).
   PubMed Web of Science ®Google Scholar
• Kim HR , ParkHS , KwonWSet al. Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer Chemother. Pharmacol.72, 825–835 (2013).
   PubMed Web of Science ®Google Scholar
• Glynn SA , BoersmaBJ , HoweTMet al. A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clin. Cancer Res.15, 4165–4173 (2009).
   PubMed Web of Science ®Google Scholar
• Bosó V , HerreroMJ , SantaballaAet al. SNPs and taxane toxicity in breast cancer patients. Pharmacogenomics15, 1845–1858 (2014).
   PubMed Web of Science ®Google Scholar
• Sookoian S , CastañoGO , BurgueñoAL , GianottiTF , RosselliMS , PirolaCJ. The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet. Genomics20, 1–8 (2010).
   PubMed Web of Science ®Google Scholar
• Suzuki A , BarnhartH , GuJet al. Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury. Liver Int.37, 1723–1730 (2017).
   PubMed Web of Science ®Google Scholar
• Andrade RJ , LucenaMI , FernandezMCet al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology129, 512–521 (2005).
   PubMed Web of Science ®Google Scholar
• Lucena MI , AndradeRJ , KaplowitzNet al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology49, 2001–2009 (2009).
   PubMed Web of Science ®Google Scholar
• Cho J , KimL , LiZ , RoseNR , TalorMV , NjokuDB. Sex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for Tregs, estrogen, and IL-6. PLoS ONE8(4), (2013).
   Web of Science ®Google Scholar
• Grossman CJ . Interactions between the gonadal steroids and the immune system. Science227, 257–261 (1985).
   PubMed Web of Science ®Google Scholar
• Wang X , HeS , GuYet al. Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis. EBioMedicine40, 251–262 (2019).
   PubMed Web of Science ®Google Scholar
• Imai Y , NakaneM , KageKet al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance 1 supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health, Labour and Welfare, Japan, and the Virtual Research Institute of Aging of Nippon Boehringer Ingelheim. 1. Mol. Cancer Ther.1, 611–616 (2002).
   PubMed Web of Science ®Google Scholar
• Zelko IN , MarianiTJ , FolzRJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med.33, 337–349 (2002).
   PubMed Web of Science ®Google Scholar
• Chan SL , ChuaAPG , AminkengFet al. Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients. PLoS ONE12, e0186200 (2017).
   PubMed Web of Science ®Google Scholar